KALARIS THERAPEUTICS INC (KLRS) Stock Income Statement
NASDAQ:KLRS • US4829291065
Current stock price
6.31 USD
+0.01 (+0.16%)
At close:
6.19 USD
-0.12 (-1.9%)
After Hours:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 55.00M | 181.33M | 171.20M | 169.82M | 71.31M | |||
| Research and Development | N/A | 133.07M | 118.87M | 120.74M | 49.66M | |||
| Selling, General, and Administrative Expenses | 43.00M | 48.26M | 52.33M | 49.08M | 21.65M | |||
| Operating Income | -55.00M | -181.33M | -171.20M | -169.82M | -71.31M | |||
| Interest Income/Expense | N/A | 5.73M | 1.88M | 1.32M | 1.33M | |||
| Other Income/Expense | 6.00M | 3.62M | 350.00K | -2.45M | 200.00K | |||
| Non Recurring Items | -10.00M | -18.57M | N/A | N/A | N/A | |||
| Income Before Taxes | -59.00M | -190.54M | -168.98M | -170.96M | -69.78M | |||
| Income Tax | 0.00 | -126.00K | -270.00K | 1.01M | N/A | |||
| Net Income | -59.00M | -190.42M | -168.71M | -171.96M | -69.78M | |||
| EBITDA | N/A | -180.93M | -170.48M | -169.63M | -71.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.78 | -1.82 | -2.20 | -2.74 | -1.13 | |||
| Non GAAP EPS | N/A | -38.41 | -51.75 | -63.02 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD